ArticleFrontiers in pharmacology2022

First-In-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of SHR2285, a Small-Molecule Factor XIa Inhibitor in Healthy Subjects.

Rui Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.